1. Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients. (20th October 2020) Authors: Patel, K.; Gooley, T. A.; Bailey, N.; Bailey, M.; Hegerova, L.; Batchelder, A.; Holdread, H.; Dunleavy, V.; Downey, T.; Frisvold, J.; Megrath, S.; Pagarigan, K.; Szeto, J.; Rueda, J.; Islam, A.; Maree, C.; Nyatsatsang, S.; Bork, S. E.; Lipke, A.; O'Mahony, D. S. Journal: Journal of internal medicine Issue: Volume 289:Number 3(2021) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗